Saturday 17 October 2026
Export MBIO’s income statement to Excel — free account
Mustang Bio, Inc.
MBIO Healthcare Biotechnology
In the quarter to June 2026, EPS grew 15.8% and free cash flow grew 27.8%, each against the same quarter a year earlier. Operating cash flow growth for three consecutive years; insiders bought in the last twelve months.
0.38
0.01
−2.56%
Follow MBIO
| Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
Current Ratio |
8.53 | 16.99 | 6.25 | 8.12 | 10.46 | 10.33 | 5.22 | 0.74 | 0.68 | 2.22 |
Net Debt/EBITDA |
2.56 | 1.92 | 1.11 | 1.10 | 1.82 | 1.68 | 0.66 | 0.13 | 0.44 | 7.22 |
Debt/Assets |
1.16% | 0.00% | 0.00% | 18.28% | 1.77% | 1.35% | 29.69% | 0.00% | 0.00% | 0.00% |
Debt/Equity |
0.01 | 0.00 | 0.00 | 0.26 | 0.02 | 0.02 | 0.59 | 0.00 | 0.00 | 0.00 |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating CF/Net income |
0.33 | 0.41 | 0.63 | 0.72 | 0.62 | 0.81 | 0.84 | 0.96 | 0.72 | 2.74 |
Capex/Depreciation |
0.00 | (1,399.50) | (12.61) | (1.78) | (1.07) | (2.33) | (0.84) | 2.51 | 0.00 | 28.41 |
Interest Coverage |
(9.90) | (3,973.12) | (3,902.87) | (25.97) | (14.50) | (4,448.20) | (22.67) | (11.99) | (3,249.00) | — |
| (125.62%) | (74.40%) | (63.73%) | (105.37%) | (79.97%) | (62.96%) | (97.72%) | (222.44%) | 840.11% | (67.93%) | |
| (92.03%) | (68.77%) | (57.72%) | (79.84%) | (65.47%) | (56.47%) | (71.26%) | (93.68%) | (116.47%) | (14.28%) | |
ROIC |
0.00% | 0.00% | (840.05%) | (781.85%) | (1,375.58%) | (933.55%) | 0.00% | 0.00% | 0.00% | 0.00% |
Return on Tangible Assets |
(52.13%) | (52.91%) | (84.32%) | (73.37%) | (61.21%) | (59.29%) | (106.00%) | 6,632.65% | 433.70% | (19.85%) |
Average Days of Receivables |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
— | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Free Cash Flow per Share |
(280.88) | (467.27) | (757.35) | (774.97) | (594.46) | (503.69) | (442.54) | (253.44) | (18.70) | (0.84) |
Cash per Share |
1,870.68 | 1,809.41 | 949.11 | 1,276.78 | 1,393.22 | 935.31 | 492.23 | 36.24 | 11.21 | 3.52 |
Shareholders Equity per Share |
1,651.43 | 1,775.43 | 1,013.82 | 1,073.85 | 1,402.21 | 959.04 | 301.06 | 0.72 | (6.35) | 1.94 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
1,651.43 | 1,775.43 | 1,013.82 | 1,073.85 | 1,402.21 | 959.04 | 301.06 | 0.72 | (6.35) | 1.94 |
Free Cash Flow |
(4.13) | (15.75) | (27.19) | (37.28) | (41.73) | (59.03) | (68.02) | (43.59) | (11.41) | (4.10) |
Working Capital |
24.28 | 57.75 | 29.51 | 55.29 | 90.02 | 100.89 | 63.74 | (4.02) | (4.00) | 9.68 |
Capital Expenditures |
— | (2.80) | (7.94) | (3.69) | (4.41) | (5.37) | (2.95) | 5.89 | 0.00 | 1.17 |
Net Current Asset Value |
24.28 | 57.70 | 28.77 | 41.27 | 88.07 | 98.94 | 32.70 | (6.27) | (4.57) | 9.53 |
| Other line items | ||||||||||
Quick Ratio |
8.53 | 16.92 | 6.07 | 7.91 | 10.28 | 10.14 | 5.03 | 0.66 | 0.57 | 2.21 |
Depreciation/Fixed assets |
0.00 | 0.00 | 0.09 | 0.26 | 0.51 | 0.21 | 0.37 | 0.72 | 2.22 | 0.00 |
Cash ROIC |
(7.93%) | (13.03%) | (38.58%) | (29.47%) | (21.06%) | (26.39%) | (45.54%) | (685.72%) | (384.69%) | (15.30%) |
Accounts Receivable Turnover |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Inventory Turnover |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | — | — |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Days of Inventory on Hand |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | — | — |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating CF per Share |
(280.88) | (384.21) | (536.04) | (698.15) | (531.61) | (457.91) | (423.33) | (287.66) | (18.70) | (1.07) |
Capex per Share |
0.00 | (83.06) | (221.31) | (76.82) | (62.85) | (45.78) | (19.21) | 34.22 | 0.00 | 0.24 |
Average Receivables |
— | 0.07 | 0.07 | 0.03 | 0.02 | 0.03 | 0.17 | 2.09 | 2.14 | 0.31 |
Average Payables |
0.35 | 2.08 | 4.43 | 5.52 | 7.21 | 9.25 | 11.74 | 13.87 | 11.75 | 7.45 |
Average Assets |
13.75 | 45.50 | 53.12 | 58.10 | 91.67 | 117.54 | 108.80 | 55.08 | 13.53 | 13.45 |
Average Common Equity |
10.07 | 42.05 | 48.11 | 44.02 | 75.04 | 105.42 | 79.34 | 23.20 | (1.87) | 2.83 |
Capex to Sales |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Columns are period end dates